Latest Aromatase inhibitor Stories
THOUSAND OAKS, Calif., Aug.
Some women who naturally produce excess estrogen in their breasts are at an increased risk for developing breast cancer, according to this study conducted by researchers at Georgetown Lombardi Comprehensive Cancer Center.
Could some women who naturally produce excess aromatase in their breasts have an increased risk of developing breast cancer?
A subset of breast cancer patients who have tumors overexpressing a protein called the human epidermal growth factor receptor 2 (HER-2 positive) may benefit from a combination of targeted treatments and may not need chemotherapy.
Cancer researchers at the Kimmel Cancer Center at Jefferson and an international team of collaborators have discovered a biomarker in breast cancer that may help identify which women will respond to anti-estrogen therapy.
Soy food consumption did not increase the risk of cancer recurrence or death among survivors of breast cancer.
The estrogen inhibitor tamoxifen can prevent breast cancer from coming back in treated women whose tumors grow in the presence of the hormone.